MA39074B1 - Polythérapie avec un anticorps anti-ang 2 et un agoniste cd40 - Google Patents

Polythérapie avec un anticorps anti-ang 2 et un agoniste cd40

Info

Publication number
MA39074B1
MA39074B1 MA39074A MA39074A MA39074B1 MA 39074 B1 MA39074 B1 MA 39074B1 MA 39074 A MA39074 A MA 39074A MA 39074 A MA39074 A MA 39074A MA 39074 B1 MA39074 B1 MA 39074B1
Authority
MA
Morocco
Prior art keywords
ang
agonist
antibody
combination therapy
binds
Prior art date
Application number
MA39074A
Other languages
English (en)
Other versions
MA39074A1 (fr
Inventor
Christian Klein
Philipp Mueller
Markus Thomas
Alfred Zippelius
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority claimed from PCT/EP2014/078233 external-priority patent/WO2015091655A1/fr
Publication of MA39074A1 publication Critical patent/MA39074A1/fr
Publication of MA39074B1 publication Critical patent/MA39074B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne la polythérapie avec un anticorps qui se lie à l'angiopoïétine 2 humaine (ang -2) avec un agoniste cd40.
MA39074A 2013-12-20 2014-12-17 Polythérapie avec un anticorps anti-ang 2 et un agoniste cd40 MA39074B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13198753 2013-12-20
PCT/EP2014/078233 WO2015091655A1 (fr) 2013-12-20 2014-12-17 Polythérapie avec un anticorps anti-ang 2 et un agoniste cd40

Publications (2)

Publication Number Publication Date
MA39074A1 MA39074A1 (fr) 2018-07-31
MA39074B1 true MA39074B1 (fr) 2019-10-31

Family

ID=49876441

Family Applications (1)

Application Number Title Priority Date Filing Date
MA39074A MA39074B1 (fr) 2013-12-20 2014-12-17 Polythérapie avec un anticorps anti-ang 2 et un agoniste cd40

Country Status (2)

Country Link
AR (1) AR098790A1 (fr)
MA (1) MA39074B1 (fr)

Also Published As

Publication number Publication date
AR098790A1 (es) 2016-06-15
MA39074A1 (fr) 2018-07-31

Similar Documents

Publication Publication Date Title
PH12016500482A1 (en) Combination therapy with an anti-ang2 antibody and a cd40 agonist
EP3784699A4 (fr) Anticorps anti-tl1a optimisés
MY191169A (en) Anti-fcrh5 antibodies
MA38273A1 (fr) Thérapie de combinaison avec des anticorps anti-her3
MA39095A1 (fr) Anticorps et immunoconjugués anti-cd33
MA52884A (fr) Anticorps anti-il-11
MA53434A (fr) Anticorps anti-tigit
EP2953643A4 (fr) Anticorps cd47 n'induisant ni l'appauvrissement en globules rouges ni l'appauvrissement en plaquettes
MA40576B1 (fr) Anticorps et immunoconjugués anti-her2
MA43187A (fr) Formulations sous-cutanée d'anticorps anti-cd38 et leurs utilisations
BR112015020911A2 (pt) anticorpo, uso de uma combinação e método de tratamento
EP3883970A4 (fr) Anticorps anti-b7-h3
MA40938A (fr) Anticorps anti-cd79b et méthodes d'utilisation desdits anticorps
MX2018001398A (es) Anticuerpos monoclonales contra bcma.
MA40682A (fr) Anticorps anti-ox40 et procédés d'utilisation correspondants
MA37538A2 (fr) Anticorps et immunoconjugués anti-ly6e et procédés d'utilisation
MA39248B1 (fr) Anticorps anti-jagged1 et procédés d'utilisation correspondants
EA201591750A1 (ru) Антитела против b7-h4 и иммуноконъюгаты
FR3021970B1 (fr) Anticorps dirige contre la galectine 9 et inhibiteur de l'activite suppressive des lymphocytes t regulateurs
EP3692072A4 (fr) Anticorps anti-hla-dq2.5
MA38797A1 (fr) Protéine de fusion thérapeutique
MX2016004853A (es) Metodos de uso de anticuerpos anti-ly6e.
EP3831851A4 (fr) Anticorps anti-btla
MA56466A (fr) Anticorps anti-epha4
UY35463A (es) Formulaciones de polipéptido fc-factor ix.